BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis

DOI: 10.1080/2162402X.2016.1185582

Keywords: BRAF V600E, immunotherapy, LCH, prognosis, targeted therapy, tumor immune microenvironment, VE1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text